CDTX vs CHPT · rev $1.3M vs rev $417.1M
Cidara Therapeutics Inc (CDTX) versus ChargePoint Holdings Inc (CHPT) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
ChargePoint Holdings Inc (CHPT) is a specialty retail company listed on NYSE.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported CHPT revenue for 2025-01-31 was $417.1M. Net income was -$277.1M. Revenue was down 17.7% from 2024-01-31 to 2025-01-31. CHPT currently screens at market cap $199.2M.
CDTX currently screens at market cap $6.96B. CHPT currently screens at market cap $199.2M.
Not investment advice. Open the CDTX and CHPT stock pages for the full models.
Not investment advice.